How Ph.D. was paid
$8.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Kristin Yarema, Ph.D.Chief Executive Officer | $274,615 | $291,918 | $1,312,468 | $6,148,382 | $138,082 | $5,733 | $8,171,198 |
| Mark Manfredi, Ph.D.Former President and Chief Executive Officer | $338,745 | $890,000 | — | $1,483,072 | — | — | $2,711,817 |
| YuFang Lu, M.D., Ph.D.Former Chief Medical Officer | $452,011 | — | $195,842 | — | — | — | $647,852 |
| Jotin Marango, M.D., Ph.D.Former Chief Financial Officer | $392,607 | $905,000 | — | $271,631 | — | — | $1,569,237 |
What changed and why
- $8.2MKristin Yarema received total compensation of $8,171,198 following her appointment as Chief Executive Officer.
- 100%The company achieved corporate goals at 100% for the 2025 fiscal year.
- $630KDr. Yarema's base salary was set at $630,000 for 2025 and increased to $680,000 for 2026.
- $890KMark Manfredi received an $890,000 bonus consisting of a transaction and retention award.
- $905KJotin Marango received a total bonus of $905,000 including retention and transaction bonuses.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.